Interleukin-4 (IL-4
I is involved in the regulation of B, T, and myeloid cells.2-10 The divergent activities of IL-4 on these cell types are initiated after binding of the ligand to the IL-4 receptor (IL4R). Receptor studies with lZ5I-labeled IL-4 on resting lymphocytes initially identified a trimolecular complex consisting of a 65-to 70-Kd doublet and a 120-Kd protein with = 300 high-affinity binding sites (kd 100 ~m o l / L ) . l~-'~ However, more recently it has been shown that the polypeptide chain with molecular weight (m.w.) of =70,000 (p70) is a breakdown product of pl2O,l5 conforming the results of the cloned murine IL-4R gene. 16 In addition, an IL-4 binding molecule with an m.w. of 40 Kd has been detected. 16 The p40 seems to be the soluble, truncated form of the receptor.l57l6 However, the soluble form of the I L 4 R has not yet been detected in human cells.17 Although there is growing knowledge about the binding properties of the IL-4R on T and B cells, myeloid cell lines, monocytes, and acute myeloid leukemic cells,11-22 there is only limited information concerning the regulation of I L 4 R gene expression in human T lymphocytes. Previous investigations have especially relied on methods using 1251-radiolabeled IL-4. In the present report we investigate the regulation of IL-4R mRNA expression in human T cells and show that I L 4 R mRNA expression can be upregulated by different activators of the intracellular signaling pathways and by IL-4. These processes are controlled at transcriptional and posttranscriptional levels. T cells were cultured in RPMI 1640 media (Flow, Rockville, MD) containing 10% fetal bovine serum (FBS; Hyclone, Logan, UT) supplemented with 100 U/mL penicillin, 100 kg/mL streptomycin, 2 mmol/L L-glutamine, and 6 ng/mL colistine.
MATERIALS AND METHODS

Preparation
Cells (5 X 106/mL) were incubated for various time periods with 25 kg/mL concanavalin A (Con A; Calbiochem, La Jolla, CA), with 50 ng/mL phorbol myristate acetate (PMA, Sigma, St Louis, MO), with 1 pmol/L calcium ionophore (A23187; Sigma), 25 kg/mL Con A + 50 ng/mL PMA, or 25 kg/mL Con A + 1 kmol/L A23187. Cycloheximide (CHX; Sigma) was used at a concentration of 10 pg/mL, actinomycin D (Act D; Boehringer, Mannheim, Germany) at 10 kg/mL, Cyclosporine A (CsA gift from Sandoz, Basel, Switzerland) at 0.1 pg/mL, and human recombinant IL-4 (gift from Dr P. Trotta, Schering Plough, Bloomfield, NJ) was used at 15 ng/mL because this concentration induced optimal response of myeloid progenitors? The specific activity of IL-4 was lo7 U/mg. Anti-IL-4 (gift from Dr P. Trotta) was used as a 1:1, OOO dilution. This dilution of anti-IL-4 neutralizes 10 ng IL-4/mL.
Total cellular RNA was isolated by the guanidinium isothiocyanate/CsCl method.23 Twelve micrograms of total RNA was electrophoresed in 2.2 mol/L formaldehyde, 1.1% agarose gels, and blotted onto nylon membranes (Hybond Nf, A m e r~h a m ) .~~ cDNA probes were labeled with [ w~~P ] dCTP (3,000 Ci/mol; Amersham, Buckinghamshire, England) by the random hexamer priming method.= The following cDNA probes were used: (1) the 0.8-kb Asp 718/Not I insert of human IL-4R cDNA purified from pBluescript (gift from Dr M.K. Sprigs, Immunex, Seattle, WA); (2) the EcoRI linearized pBr322
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mRNA extraction and analysis.
plasmid containing a 7.8-kb human 28s cDNA insert; (3) the 0.45-kb EcoRIIAva I1 insert of human granulocyte-macrophage colony-stimulating factor (GM-CSF) cDNA (gift from Dr S. Gillis, Immunex).
Hybridization was performed at 65°C for 18 hours in 0.5 mol/L Na2HP04, pH 7.2, 1 mmol/L EDTA, 7% sodium dodecyl sulfate (SDS). Membranes were washed once in 2 x SSC, 0.1% SDS; once in l x SSC, 0.1% SDS; and finally in 0 . 3~ SSC, 0.1% SDS for 20 minutes at 65°C. The membranes were exposed to Kodak X-Omat XAR films (Eastman Kodak, Rochester, NY) at -80°C using an intensifying screen. Quantification of mRNA levels was performed by densitometry using a Gel Scan laser densitometer (Pharmacia LKB, Uppsala, Sweden).
For the nuclear run-on assay, 1@ cells were pelleted at SO(& for 5 min, washed twice with ice-cold phosphate-buffered saline (PBS), and suspended in 4 mL of lysis-buffer (10 mmol/L Tris-HCL, pH 7.5, 3 mmol/L MgC12, 10 mmol/L NaCI, 0.5% NP-40). After gentle vortexing, the suspension was incubated on ice for 5 minutes. Nuclei were pelleted at 5OOg for 5 minutes and the lysis described above was repeated. Hybridization of labeled RNA to these membranes was as described above. Washingwas as described above except that an extra wash step with 2 x SSC/l pg/mL RNase A (Boehringer) was included. Exposure and quantification of transcription rate levels were performed as described above.
T lymphocytes were treated for 24 hours with 25 pg/mL Con A. After washing, the cells were resuspended in RPMI 1640 medium. Aliquots of about 106 cells were analyzed with respect to IL-4R expression by incubating these cells first with human IgG for 10 minutes at 4°C to block nonspecific binding. Subsequently, the cells were incubated with 2 pg mouse-antihuman IL-4R MoAb (gift from Dr S. a concentration of l@ cell/mL in a HEPES-buffered saline, containing 137 mmol/LNaCI, 5 mmol/LKCI, 1 mmol/L Na2HP04, 5 mmol/L glucose, 1 mmol/L CaC12, 0.5 mmol/L MgC12, bovine serum albumin 1 g/L, HEPES 10 mmol/L pH 7.4. Cells were incubated for 10 minutes at 37°C and treated with medium (negative control), 15 ng/mL IL-4, or 25 pg/mL Con A (positive control). Cells were analyzed on FACS after 0, 10, 20, 40, and 60 minutes of Con A or IL-4 treatment. The excitation wavelength was set to 488 nm and the emission at 525 nm was measured on a linear scaleZX during 3 minutes for each experiment. Temperature was maintained at 37°C throughout the experiment. Results are expressed as mean fluorescence of events.
RESULTS
Regulation of IL-4R expression on activation of different intracellular signaling pathways. The regulation of IL-4R gene expression was studied at mRNA and protein level in human T cells in response to stimulation of different intracellular signaling pathways. Exposure to Con A, PMA, A23187, Con A + PMA, and Con A + A23187 resulted in a fourfold to fivefold increased expression of IL-4R mRNA as determined by Northern blotting (Fig 1) . Optimal accumulation of IL-4R mRNA was observed after 2 to 4 hours of stimulation with these activators. IL-4R mRNA levels returned to baseline levels after 6 to 8 hours of exposure (data not shown). No additive effect was observed when Con A plus PMA or Con A plus A23187 was used compared with the effects of the individual agents (Fig 1) . To determine whether the increased accumulation of IL-4R mRNA was caused by an increase in transcription rate, nuclear run-on assays were performed.
A representative experiment is shown in For To study whether posttranscriptional mechanisms are also involved, the stability of IL-4R mRNA was examined. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From
IL-
DOKTER ET AL
Con A + A23187 did not further increase the stability of the IL4R transcript (Fig 3) . In contrast, rehybridizing with a GM-CSF probe demonstrated a stabilizing effect of PMA on Con A-induced GM-CSF transcripts (data not shown).
In addition, experiments were performed with CHX to test whether expression of the IL-4R gene was dependent on ongoing protein synthesis. No difference in the accumulation of ILdR mRNA was observed on stimulation with Con A, PMA, Con A + PMA, or Con A + A23187 in the presence or absence of CHX (Fig 4) . In contrast, A23187-induced IL-4R mRNA expression was inhibited by CHX, indicating that only the calcium-dependent upregulation of IL-4R expression is a protein synthesis-dependent process. To demonstrate the effectiveness of CHX, the filter was rehybridized with a GM-CSF probe and demonstrated a strong reduction in accumulation of GM-CSF mRNA in the presence of CHX (data not shown).
Finally, the effects of the immunosuppressive drug CsA on the expression of the IL4R in activated T cells were studied. As depicted in (Fig 7) . In addition, it was demonstrated that IL-4 modulates IL-4R mRNA at the posttranscriptional level. The half-life of the IL-4R mRNA was prolonged to 140 to 160 minutes after stimulation with IL-4 (Fig 8) .
Contribution of Ca2+ and protein kinase C (PKC) dependent pathways.
To further analyze the contribution of PKC-dependent pathways in regulating IL-4R mRNA lev- Fig 9. The effects of Con A were also tested in the presence of anti-IL-4 to exclude the possibility that the Con A-mediated upregulation was caused by secreted IL-4 in response to Con A stimulation.29Jo However, no difference in expression was noticed in the absence or presence of anti-IL-4.
Regulation of IL-4R protein.
DISCUSSION
Since the cloning of the IL-4R cDNA16J7 it has become possible to study the expression of the IL4R gene in detail.
In the present report, we examine the control of IL-4R expression in human T cells and show that different 
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pathways regulate IL4R gene expression. Firstly, constitutively expressed IL-4R mRNA in resting T cells could be upregulated by activators of different secondary signaling pathways such as Con A, PMA, and A23187. Upon treatment, an approximate fourfold increase in IL4R mRNA accumulation was shown that could be ascribed to a moderate increase in transcription rate of the IL-4R gene and to stabilization of the IL-4R transcripts. The combinations of factors did not further augment the IL4R expression. Secondly, IL-4 upregulated the IL4R mRNA accumulation, which was accomplished at both transcriptional and posttranscriptional levels. However, the increase in IL4R transcription rate as well as the stabilization at posttranscriptional level were more pronounced by IL-4 than by Con A, PMA, A23187 or combinations of these agents. These data suggest that upregulation of the IL-4R by IL-4 depends on additional signaling pathways, besides the PKC and Ca2+ route. Alternatively, IL-4 exhibits its effect independent of the PKC-and Ca2+-dependent pathway. This is also supported by the findings that binding of IL-4 to the receptor on murine B cells did not stimulate Ca2+ mobilization or PKC t r a n s l~c a t i o n .~~~~~ Furthermore, inactivation of PKC This could indicate that this first peak at 3 hours is followed by a second peak of IL-4R mRNA expression at 45 hours. This is underscored by our observation that Con A-treated T cells expressed a second peak of IL-4R mRNA accumulation after 24 hours of stimulation (unpublished results, December 1991).
Furthermore, evidence was obtained that IL-4R expression is less stringent controlled than IL-4 expression in human T cells as was described for IL-2 and its receptor. The interactive process between IL-4 and its receptor may be an important immunoregulatory process. The binding of IL-4 to the receptor provides T lymphocytes the possibility to respond continuously to exogenous IL-4 by upregulating the receptor expression and subsequently to be controlled by the modulatory effects of this cytokine.
In conclusion, we demonstrate that regulation of IL-4R gene expression is controlled at both transcriptional and posttranscriptional levels by IL-4 and in response to different activation signals. 
